Gemcitabine Injection IP 1g – Anti Cancer Lyophilized Injection Third Party Manufacturing by Medizia Oncocare Gemcitabine Injection IP 1g is part of the specialized anti cancer lyophilized injection portfolio offered by Medizia Oncocare for licensed pharmaceutical companies, distributors, hospitals, institutional buyers and other...
Gemcitabine Injection IP 200mg – Anti Cancer Lyophilized Injection Third Party Manufacturing | Medizia Oncocare Medizia Oncocare offers Gemcitabine Injection IP 200mg as part of its specialized anti cancer lyophilized injection third party manufacturing portfolio for licensed pharmaceutical companies, distributors, hospital...
Azacitidine for Injection IP 100mg – Anti Cancer Lyophilized Injection Third Party Manufacturing | Medizia Oncocare Medizia Oncocare offers Azacitidine for Injection IP 100mg as part of its specialized anti cancer lyophilized injection third party manufacturing portfolio for licensed pharmaceutical companies, distributors,...
Dactinomycin for Injection USP 0.5mg – Anti Cancer Lyophilized Injection Third Party Manufacturing | Medizia Oncocare Medizia Oncocare offers Dactinomycin for Injection USP 0.5mg as part of its specialized anti cancer lyophilized injection third party manufacturing portfolio for licensed pharmaceutical companies, distributors,...
Bendamustine Injection IP 100mg – Anti Cancer Lyophilized Injection Third Party Manufacturing | Medizia Oncocare Medizia Oncocare offers Bendamustine Injection IP 100mg as part of its specialized anti cancer lyophilized injection third party manufacturing portfolio for licensed pharmaceutical companies, oncology distributors,...